These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19366125)

  • 41. Matrix metalloproteinases and their regulators are cardiovascular therapeutic targets.
    Luft FC
    J Mol Med (Berl); 2004 Dec; 82(12):781-3. PubMed ID: 15551107
    [No Abstract]   [Full Text] [Related]  

  • 42. Laminitis: drink deep, or taste not the Pierian Spring.
    Silver IA
    Equine Vet J; 2008 Jul; 40(5):431-2. PubMed ID: 18678553
    [No Abstract]   [Full Text] [Related]  

  • 43. Angiotensin II receptor blockade improves matrix metalloproteinases/tissue inhibitor of matrix metalloproteinase-1 balance and restores fibronectin expression in rat infarcted myocardium.
    Yang D; Ma S; Li D; Tang B; Yang Y
    Biochem Biophys Res Commun; 2009 Oct; 388(3):606-11. PubMed ID: 19695229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Matrix metalloproteinases in the pathogenesis of viral heart disease.
    Marchant D; McManus BM
    Trends Cardiovasc Med; 2009 Jan; 19(1):21-6. PubMed ID: 19467450
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A continuum model for the development of tissue-engineered cartilage around a chondrocyte.
    Trewenack AJ; Please CP; Landman KA
    Math Med Biol; 2009 Sep; 26(3):241-62. PubMed ID: 19581342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metalloproteolytic balance in asthma: when and how could its regulation?
    Gardella C; Panigada S; Rossi GA
    Respir Med; 2009 Nov; 103(11):1589-91. PubMed ID: 19596187
    [No Abstract]   [Full Text] [Related]  

  • 47. Interleukin-1beta-induced extracellular matrix degradation and glycosaminoglycan release is inhibited by curcumin in an explant model of cartilage inflammation.
    Clutterbuck AL; Mobasheri A; Shakibaei M; Allaway D; Harris P
    Ann N Y Acad Sci; 2009 Aug; 1171():428-35. PubMed ID: 19723086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Structure and function of matrix metalloproteinases].
    Olszyński K; Zimowska M
    Postepy Biochem; 2009; 55(1):76-84. PubMed ID: 19514468
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Matrix metalloproteinases: key regulators in the pathogenesis of chemotherapy-induced mucositis?
    Al-Dasooqi N; Gibson RJ; Bowen JM; Keefe DM
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):1-9. PubMed ID: 19305997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Confocal microscopy indentation system for studying in situ chondrocyte mechanics.
    Han SK; Colarusso P; Herzog W
    Med Eng Phys; 2009 Oct; 31(8):1038-42. PubMed ID: 19586793
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Matrix metalloproteinases in pathophysiology and treatment of heart failure.
    Feldman AM; Li YY; McTiernan CF
    Lancet; 2001 Mar; 357(9257):654-5. PubMed ID: 11247546
    [No Abstract]   [Full Text] [Related]  

  • 52. Contribution of the fibrinolytic pathway to hematopoietic regeneration.
    Heissig B; Ohki M; Ishihara M; Tashiro Y; Nishida C; Gritli I; Rosenkvist J; Hattori K
    J Cell Physiol; 2009 Dec; 221(3):521-5. PubMed ID: 19681053
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The involvement of metalloproteinases and their tissular inhibitors in the processes of periodontal orthodontic remodeling.
    Surlin P; Rauten AM; Mateescu GO; Oprea B; Mariş M; Manolea H
    Rom J Morphol Embryol; 2009; 50(2):181-4. PubMed ID: 19434308
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Matrix metalloproteinases in the pathophysiology and progression of gynecological malignancies: could their inhibition be an effective therapeutic approach?
    Memtsas V; Zarros A; Theocharis S
    Expert Opin Ther Targets; 2009 Sep; 13(9):1105-20. PubMed ID: 19604124
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Matrix metalloproteinases and their tissue inhibitors in children and young adults on chronic hemodialysis--preliminary results].
    Musiał K; Makulska I; Zwolńska D
    Pol Merkur Lekarski; 2009 Apr; 26(154):290-3. PubMed ID: 19580190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells.
    Ito I; Fixman ED; Asai K; Yoshida M; Gounni AS; Martin JG; Hamid Q
    Clin Exp Allergy; 2009 Sep; 39(9):1370-80. PubMed ID: 19522858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Placental expression of proteases and their inhibitors in patients with HELLP syndrome.
    von Steinburg SP; Krüger A; Fischer T; Mario Schneider KT; Schmitt M
    Biol Chem; 2009 Nov; 390(11):1199-204. PubMed ID: 19663680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cleaved high molecular weight kininogen, a novel factor in the regulation of matrix metalloproteinases in vascular smooth muscle cells.
    Vosgerau U; Lauer D; Unger T; Kaschina E
    Biochem Pharmacol; 2010 Jan; 79(2):172-9. PubMed ID: 19682438
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of betamethasone on inflammation and emphysema induced by cadmium nebulisation in rats.
    Fiévez L; Kirschvink N; Zhang WH; Lagente V; Lekeux P; Bureau F; Gustin P
    Eur J Pharmacol; 2009 Mar; 606(1-3):210-4. PubMed ID: 19374854
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aging-related differences in chondrocyte viscoelastic properties.
    Steklov N; Srivastava A; Sung KL; Chen PC; Lotz MK; D'Lima DD
    Mol Cell Biomech; 2009 Jun; 6(2):113-9. PubMed ID: 19496259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.